Note that the Relapsing-remitting group comprises the clinical groups: RR-MS Remission, RR-MS Active, RESPONDERS, NON RESPONDERS and RELAPSES. The Progressive group comprises Secondary (SP-MS) and Primary-progressive patients ,
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis, The American Journal of Pathology, vol.172, issue.1, pp.146-55, 2007. ,
DOI : 10.2353/ajpath.2008.070690
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles, Journal of Neuroimmunology, vol.175, issue.1-2, pp.176-82, 2006. ,
DOI : 10.1016/j.jneuroim.2006.03.004
Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis, Neurology, vol.44, issue.8, pp.1523-1529, 1994. ,
DOI : 10.1212/WNL.44.8.1523
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity, Journal of neuroimmunology, vol.66, issue.12, pp.57-64, 1996. ,
Increased release of interleukin-12p40 in MS: Association with intracerebral inflammation, Neurology, vol.51, issue.3, pp.753-761, 1998. ,
DOI : 10.1212/WNL.51.3.753
Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis, Journal of Neuroimmunology, vol.120, issue.1-2, pp.152-60, 2001. ,
DOI : 10.1016/S0165-5728(01)00398-8
Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients, Journal of Neural Transmission, vol.112, issue.6, pp.797-803, 2005. ,
DOI : 10.1007/s00702-004-0225-9
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011. ,
DOI : 10.1002/ana.22366
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983. ,
DOI : 10.1212/WNL.33.11.1444
The expression and function of chemokines involved in CNS inflammation Trends in pharmacological sciences, Epub, vol.27, issue.1, pp.48-55, 2005. ,
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies, Acta Neurologica Scandinavica, vol.57, issue.3, pp.137-183, 2007. ,
DOI : 10.1002/eji.200535195
The Chemokine System in Neuroinflammation: An Update, The Journal of Infectious Diseases, vol.186, issue.s2, pp.152-158, 2002. ,
DOI : 10.1086/344266
Expression of CSF- 1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis ,
Chemokine expression in murine experimental allergic encephalomyelitis, Journal of Neuroimmunology, vol.58, issue.2, pp.167-76, 1995. ,
DOI : 10.1016/0165-5728(95)00008-P
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis, Neurologic clinics. Epub, vol.13, issue.1, pp.51-73, 1995. ,
The Role of Cytokines in Experimental Autoimmune Encephalomyelitis, Archivum immunologiae et therapiae experimentalis. Epub, vol.48, issue.5, pp.389-98, 2000. ,
DOI : 10.1007/978-94-010-0981-2_9
Experimental Autoimmune Encephalomyelitis on the SJL Mouse: Effect of ???? T Cell Depletion on Chemokine and Chemokine Receptor Expression in the Central Nervous System, The Journal of Immunology, vol.164, issue.4, pp.2120-3005, 2000. ,
DOI : 10.4049/jimmunol.164.4.2120
Chemokines and disease, Nature Immunology, vol.2, issue.2, pp.108-123, 2001. ,
DOI : 10.1038/84209
Chemokines in autoimmune disease Current opinion in immunology, Epub, vol.131026, issue.601, pp.670-675, 2001. ,
Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis, Brain, vol.124, issue.10, pp.1927-1965, 2001. ,
DOI : 10.1093/brain/124.10.1927
Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation, Journal of Neuroimmunology, vol.133, issue.1-2, pp.95-107, 2002. ,
DOI : 10.1016/S0165-5728(02)00366-1
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, Nature Medicine, vol.158, issue.5, pp.500-508, 2002. ,
DOI : 10.1038/ng0896-464
Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune Encephalomyelitis, Scandinavian Journal of Immunology, vol.183, issue.1, pp.81-89, 2003. ,
DOI : 10.1046/j.1365-3083.2003.01285.x
CCL5 induces a pro-inflammatory profile in microglia in vitro, Cellular Immunology, vol.270, issue.2, pp.164-71, 2011. ,
DOI : 10.1016/j.cellimm.2011.05.001
An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians, BMC Medical Genetics, vol.72, issue.4, pp.64-1550395, 2006. ,
DOI : 10.1172/JCI117788
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis, Genes and Immunity, vol.179, issue.2, pp.142-54, 2009. ,
DOI : 10.1016/j.jneuroim.2009.01.014
Involvement of beta-chemokines in the development of inflammatory demyelination, Journal of neuroinflammation. Epub, vol.2, issue.17, p.554759, 1742. ,
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats, PLoS ONE, vol.166, issue.7, pp.39794-3397980, 2012. ,
DOI : 10.1371/journal.pone.0039794.s008
Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain, The Journal of Cell Biology, vol.126, issue.2, pp.485-94, 1994. ,
DOI : 10.1083/jcb.126.2.485
TGF-?-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway, European Journal of Immunology, vol.120, issue.3, pp.727-764, 2005. ,
DOI : 10.1002/eji.200425430
Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors Stem cells and development, Epub, vol.15, issue.6, pp.943-52, 2006. ,
Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury, Experimental Neurology, vol.233, issue.1, pp.312-334, 2011. ,
DOI : 10.1016/j.expneurol.2011.10.021
Mechanism of met oncogene activation, Cell, vol.45, issue.6, pp.895-904, 1986. ,
DOI : 10.1016/0092-8674(86)90564-7
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product, Science, vol.251, issue.4995, pp.802-806, 1991. ,
DOI : 10.1126/science.1846706
Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor, Molecular Brain Research, vol.32, issue.2, pp.197-210, 1995. ,
DOI : 10.1016/0169-328X(95)00075-4
Expression of HGF and cMet in the developing and adult brain, Developmental Brain Research, vol.102, issue.2, pp.299-303, 1997. ,
DOI : 10.1016/S0165-3806(97)00108-9
Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway, The Journal of experimental medicine. PMID, vol.18516, issue.12, pp.2121-2152, 1997. ,
Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells., Proceedings of the National Academy of Sciences, vol.91, issue.15, pp.7144-7152, 1994. ,
DOI : 10.1073/pnas.91.15.7144
The impact of c-met/scatter factor receptor on dendritic cell migration, 7<1832::AID-IMMU1832>3.0.CO;2-2 PMID, pp.1832-1840, 2002. ,
DOI : 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2
The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity, The Journal of Immunology, vol.189, issue.4, pp.1699-707, 2012. ,
DOI : 10.4049/jimmunol.1200729
Hepatocyte growth factor in cerebrospinal fluid in neurologic disease, Acta Neurologica Scandinavica, vol.251, issue.2, pp.99-103, 2002. ,
DOI : 10.1016/S0006-8993(97)00958-X
CONCENTRATIONS OF HEPATOCYTE GROWTH FACTOR IN CEREBROSPINAL FLUID UNDER NORMAL AND DIFFERENT PATHOLOGICAL CONDITIONS, Cytokine, vol.14, issue.3, pp.170-176, 2001. ,
DOI : 10.1006/cyto.2001.0875
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis, Journal of Neuroimmunology, vol.251, issue.1-2, pp.80-86, 2012. ,
DOI : 10.1016/j.jneuroim.2012.06.008
Review: Glial lineages and myelination in the central nervous system, Journal of Anatomy, vol.190, issue.2, pp.161-200, 1997. ,
DOI : 10.1046/j.1469-7580.1997.19020161.x
Epidermal Growth Factor Induces the Progeny of Subventricular Zone Type B Cells to Migrate and Differentiate into Oligodendrocytes, Stem Cells, vol.9, issue.8, pp.2032-2075, 2009. ,
DOI : 10.1002/stem.119
Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis. Restorative neurology and neuroscience, Epub, vol.29, issue.4, pp.243-52, 2011. ,
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis, Brain Research, vol.1333, pp.64-71, 2010. ,
DOI : 10.1016/j.brainres.2010.03.073
FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions, Journal of Neuroscience, vol.31, issue.42, pp.14899-909, 2011. ,
DOI : 10.1523/JNEUROSCI.1158-11.2011
Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo, Experimental Neurology, vol.192, issue.1, pp.125-158, 2005. ,
DOI : 10.1016/j.expneurol.2004.11.007
Fibroblast Growth Factor-2 Inhibits Myelin Production by Oligodendrocytes in Vivo, Molecular and Cellular Neuroscience, vol.18, issue.5, pp.557-69, 2001. ,
DOI : 10.1006/mcne.2001.1025
Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro, Experimental Neurology, vol.184, issue.2 ,
DOI : 10.1016/j.expneurol.2003.08.019
Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis, Immunology, vol.275, issue.3, pp.370-378, 2011. ,
DOI : 10.1111/j.1365-2567.2011.03450.x
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients, Neuroscience Letters, vol.435, issue.3, pp.223-231, 2008. ,
DOI : 10.1016/j.neulet.2008.02.040
Clinical applications of angiogenic growth factors and their inhibitors, Nature Medicine, vol.5, issue.12, pp.1359-64, 1999. ,
DOI : 10.1038/70928
Mechanisms of angiogenesis and arteriogenesis, Nature Medicine, vol.6, issue.4, pp.389-95, 2000. ,
DOI : 10.1038/74651
Vascular-specific growth factors and blood vessel formation, Nature, vol.407, issue.6801, pp.242-250, 2000. ,
DOI : 10.1038/35025215
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment, Journal of Clinical Investigation, vol.113, issue.7, pp.1040-50, 2004. ,
DOI : 10.1172/JCI20465
VEGF-mediated inflammation precedes angiogenesis in adult brain, Experimental Neurology, vol.187, issue.2, pp.388-402, 2004. ,
DOI : 10.1016/j.expneurol.2004.02.010
Role and Therapeutic Potential of VEGF in the Nervous System, Physiological Reviews, vol.89, issue.2, pp.607-48607, 2008. ,
DOI : 10.1152/physrev.00031.2008
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis, Magnetic Resonance in Medicine, vol.17, issue.3, pp.285-93, 1994. ,
DOI : 10.1002/mrm.1910320303
Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings, S0022-510X(05)00417-X, pp.21-30, 2005. ,
DOI : 10.1016/j.jns.2005.11.006
Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult, Brain Pathology, vol.73, issue.4, pp.554-7306, 2003. ,
DOI : 10.1111/j.1750-3639.2003.tb00485.x
Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats, Journal of Neuropathology & Experimental Neurology, vol.61, issue.10, pp.61914-61939, 2002. ,
DOI : 10.1093/jnen/61.10.914
The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis, PLoS ONE, vol.34, issue.5, p.19138, 2011. ,
DOI : 10.1371/journal.pone.0019138.s004
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease, Journal of the Neurological Sciences, vol.195, issue.1, pp.41-47, 2002. ,
DOI : 10.1016/S0022-510X(01)00680-3
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis, European Journal of Neurology, vol.103, issue.6, pp.665-72, 2001. ,
DOI : 10.1016/S1074-7613(00)80165-X
Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis, Acta Neurologica Scandinavica, vol.154, issue.2, pp.88-91, 2001. ,
DOI : 10.1016/S0165-5728(97)00040-4
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis, Journal of Neuroimmunology, vol.149, issue.1-2, pp.182-188, 2004. ,
DOI : 10.1016/j.jneuroim.2003.12.010
Essential Contribution of Monocyte Chemoattractant Protein-1/C-C Chemokine Ligand-2 to Resolution and Repair Processes in Acute Bacterial Pneumonia, The Journal of Immunology, vol.172, issue.1, pp.398-409, 2003. ,
DOI : 10.4049/jimmunol.172.1.398
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients, Journal of Clinical Investigation, vol.103, issue.6, pp.807-822, 1999. ,
DOI : 10.1172/JCI5150
Expression of monocyte chemoattractant pro- tein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions, Journal of neuroimmunology, vol.8417, issue.206, pp.238-287, 1998. ,
The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease, European Journal of Neurology, vol.103, issue.1, pp.49-54, 2004. ,
DOI : 10.1016/S1074-7613(00)80165-X
Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling, Journal of Neuroimmunology, vol.114, issue.1-2, pp.207-219, 2001. ,
DOI : 10.1016/S0165-5728(00)00456-2
Steroid Therapy Altered Serum Levels of CCL2 and CCL5 Chemokines in Multiple Sclerosis Patients during Relapse, European Neurology, vol.52, issue.4, pp.237-278, 2004. ,
DOI : 10.1159/000082164
CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1?? and IP-10 are expressed in demyelinating brain lesions, Proceedings of the National Academy of Sciences, vol.96, issue.12, pp.6873-6881, 1999. ,
DOI : 10.1073/pnas.96.12.6873
Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5, Brain: a journal of neurology, vol.12326, issue.08, pp.1874-82, 2000. ,
Evaluation of Serum Levels of Chemokines during Interferon-?? Treatment in Multiple Sclerosis Patients, CNS Drugs, vol.104, issue.2, pp.971-81, 2011. ,
DOI : 10.2165/11595060-000000000-00000
Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis, Archives of Neurology, vol.66, issue.10, pp.1216-1239, 2009. ,
DOI : 10.1001/archneurol.2009.138
response to interferon-?? treatment in multiple sclerosis using DNA-array evaluation, European Journal of Neurology, vol.70, issue.12, pp.1291-1299, 2009. ,
DOI : 10.1111/j.1468-1331.2009.02716.x
Interferon ??-1b modulates MCP-1 expression and production in relapsing???remitting multiple sclerosis, Journal of Neuroimmunology, vol.123, issue.1-2, pp.170-179, 2002. ,
DOI : 10.1016/S0165-5728(01)00487-8
Interferon ?? decreases T cell activation and interferon ?? production in multiple sclerosis, Journal of Neuroimmunology, vol.46, issue.1-2, pp.145-53, 1993. ,
DOI : 10.1016/0165-5728(93)90244-S
Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand, Proceedings of the National Academy of Sciences, vol.94, issue.2, pp.599-603, 1997. ,
DOI : 10.1073/pnas.94.2.599
Chemokines and leukocyte traffic, Nature, vol.392, issue.6676, pp.565-573, 1998. ,
DOI : 10.1038/33340